Implementation of a registry for acute coronary syndrome in resource-limited settings: Barriers and opportunities

Asia-Pacific Journal of Public Health

Volumn 22, Issue SUPPL. 3, 2010, Pages

  Safavi, Kyan ^a   Linnander, Erika L ^a   Allam, A A ^b   Bradley, Elizabeth H ^a   Krumholz, Harlan M ^a  

^a YALE UNIVERSITY   (United States)

^b AL AZHAR UNIVERSITY   (Egypt)

Author keywords

cardiovascular disease; clinical registry; Egypt; outcomes research; quality improvement

Indexed keywords

ACUTE CORONARY SYNDROME; ARTICLE; DEVELOPING COUNTRY; EGYPT; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; INFORMATION PROCESSING; OBSERVATION; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PILOT STUDY; REGISTER;

ACUTE CORONARY SYNDROME; DATA COLLECTION; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; EGYPT; HEALTH SERVICES ACCESSIBILITY; HUMANS; OBSERVATION; ORGANIZATIONAL CULTURE; PILOT PROJECTS; QUALITY ASSURANCE, HEALTH CARE; REGISTRIES;

EID: 77953830336     PISSN: 10105395     EISSN: None     Source Type: Journal    
DOI: 10.1177/1010539510373017     Document Type: Conference Paper

References (8)

1. World Health Organization. World Health Statistics 2006. Table: Death and DALY estimates by cause. Geneva Switzerland: World Health Organization; 2007.
2. Mathers CD, Lopez AD, Murray CJL. The burden of disease and mortality by condition: data, methods, and results for 2001. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, eds. Global Burden of Disease and Risk Factors. New York, NY: Oxford University Press ; 2006: 49-240.
3. Butler J., Kalogeropoulos A. Registries and health care quality improvement. J Am Coll Cardiol. 2009 ; 54: 1290-1292.
4. Alexander KP, Chen AY, Roe MT, et al. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA. 2005 ; 294: 3108-3116.
5. Balcezak TJ, Krumholz HM, Getnick GS, Vaccarino V., Lin ZQ, Cadman EC Utilization and effectiveness of a weight-based heparin nomogram at a large academic medical center. Am J Manag Care. 2000 ; 6: 329-338.
6. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994 ; 343: 311-322.
7. Bradley EH, Herrin J., Wang Y., et al. Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA. 2004 ; 292: 1563-1572.
8. Peterson ED, Roe MT, Rumsfeld JS, et al. A call to ACTION (Acute Coronary Treatment and Intervention Outcomes Network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2009 ; 2: 491-499.